Where does Stichting Maastricht Radiation Oncology Maastro Clinic rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Stichting Maastricht Radiation Oncology Maastro Clinic ranks #37,699 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is Stichting Maastricht Radiation Oncology Maastro Clinic's patent grant rate increasing or decreasing?

Stichting Maastricht Radiation Oncology Maastro Clinic's recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Stichting Maastricht Radiation Oncology Maastro Clinic's patents?

Stichting Maastricht Radiation Oncology Maastro Clinic's patents average 16.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Stichting Maastricht Radiation Oncology Maastro Clinic

Q: How many patents does Stichting Maastricht Radiation Oncology Maastro Clinic hold?

Stichting Maastricht Radiation Oncology Maastro Clinic holds 7 US utility patents granted between 2015 and 2024, spanning 10 technology areas.

Q: What is Stichting Maastricht Radiation Oncology Maastro Clinic's Innovation Score?

Stichting Maastricht Radiation Oncology Maastro Clinic has an Innovation Score of 38.4 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Q: What technology areas does Stichting Maastricht Radiation Oncology Maastro Clinic focus on?

Stichting Maastricht Radiation Oncology Maastro Clinic's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 4 patents, ranking #3,645 of 7,127 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Q: How is the Stichting Maastricht Radiation Oncology Maastro Clinic patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Stichting ranks #37,699 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 10 technology areas.

#37,699
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.4/100): 16.7
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R37699 · Foreign Corporation #37,699 · 7 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 7 grants
LOWER-Q #37,699/49,997
PHOTO-FINISH Stefano Ricci S P A
CPC-FOCUS A61B · 10 areas
INNOV-THIN 38.4/100
CLAIMS-RICH 16.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Stefano Ricci S.P.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Stichting’s 38.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (19%) Velocity 10.0 pts (26%) Breadth 11.2 pts (29%) Claim depth 10.0 pts (26%)

Qualcomm Incorporated · highest

85
Stichting Maastricht… · this assignee

38
3D Lighting… · lowest

7

What this shows Stichting's Innovation Score is 38.4/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Stichting?

Each dot is one of Stichting’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Stichting’s own 16.7 claims/patent is ABOVE the 7.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Stichting vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Stichting's grants concentrate

Stichting Maastricht Radiation Oncology Maastro Clinic is a focused PatentsView assignee: 10 CPC subclasses with 57.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2015. By volume, Stichting sits between Stefano Ricci S.P.A. and STMicroelectronics. KK.

Stichting's three-year grant acceleration

Stichting Maastricht Radiation Oncology Maastro Clinic shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Stefano Ricci S P…

7
Stek

7
Stella Mccartney

7
Steyr Mannlicher

7
Still

7
Stmec

7
Stmicroelectron S…

7
Stmicroelectronic…

7
Stichting Maastri… ◀

7

What this shows Stichting holds 7 patents at rank #37,490, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Stichting

By rank, the assignees closest to #37,490 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Stichting's primary technology class.

Stichting's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Stichting Maastricht Radiation Oncology Maastro Clinic patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	14.3%
2017	1	14.3%
2019	2	28.6%
2022	2	28.6%
2024	1	14.3%

Which technologies does Stichting Maastricht Radiation Oncology Maastro Clinic patent most?

A61B - DIAGNOSIS; SURGERY; Identification 4

G06T - Image Data Processing OR Generation, IN General 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

G06V - Image OR Video Recognition OR Understanding 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

G01T - Measurement OF Nuclear OR X-radiation 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

C07D - Heterocyclic Compounds 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

G06F - Electric Digital Data Processing 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Stichting Maastricht Radiation Oncology Maastro Clinic's patent record in context - here's where to go next.

Stichting Maastricht Radiation Oncology Maastro Clinic's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 57.1% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #37,699 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Stichting Maastricht Radiation Oncology Maastro Clinic against Stefano Ricci S.P.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.